Nimbus Therapeutics

@NimbusTx

We integrate computational chemistry and other advanced technologies to design breakthrough medicines and transform drug development.

Vrijeme pridruživanja: studeni 2016.

Tweetovi

Blokirali ste korisnika/cu @NimbusTx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NimbusTx

  1. prije 13 sati

    We’re excited to share something that’s been cooking here within Nimbus in recent months: The crystallization of our core values. These four ideas really sum up the DNA of a Nimbi. Explore them here:

    Poništi
  2. 27. sij

    At Nimbus, we use a range of technologies, including X-ray crystallography and , to generate high-resolution structural data on our drug targets. Learn more about our structure-based engine here:

    Poništi
  3. 9. sij

    Check out this recent podcast featuring Nimbus’ own Carl Harkness talking about what goes on behind the scenes to power our global network of collaborations doing cutting-edge science. (Hint: Smart workflows, automation, and lots of coffee!) Listen here:

    Poništi
  4. 6. sij

    We’re looking forward to seeing everyone at next week. Drop us a line if you’d like to meet up!

    Poništi
  5. 2. sij

    The Nimbus team wants to wish everyone a ! 2019 was a wonderful year — from celebrating to continued growth of our expert team — and we're entering the next decade with immense excitement for what's to come.

    Poništi
  6. 23. pro 2019.

    Recently our team took time to put together outfit packs — backpacks containing winter clothes — and delivered them to our partner . We're glad to say that more Massachusetts residents will now be winter ready! Learn more about CASPAR here:

    Poništi
  7. 20. pro 2019.

    Wishing you and yours a wonderful holiday season, from all of us at Nimbus!

    Poništi
  8. 17. pro 2019.

    As we gear up to once again become a clinical-stage company, we’re thrilled to share some exciting news: Our CMO Annie Chen has been promoted to also become president of our Tyk2 subsidiary. Learn more:

    Poništi
  9. proslijedio/la je Tweet
    17. pro 2019.

    Such a pleasure to work with Annie over the last several years. She'll continue to be CMO for all of Nimbus and add executive functions for Tyk2. No better choice to lead our Tyk2 program and critical decisions going forward!

    Poništi
  10. 6. pro 2019.

    Head of Christine Loh has only been a Nimbi for a few months now, but has immersed herself in/has fully engaged on the science & drug discovery with the team. We are proud and lucky to have her!

    Poništi
  11. 2. pro 2019.

    We're excited to share some updates to our website! Check out our redesigned Approach page and then click through to see our improved pipeline layout:

    Poništi
  12. 27. stu 2019.

    Happy Thanksgiving from the Nimbus team!

    Poništi
  13. 13. stu 2019.

    Spreading kindness in our community is a priority at Nimbus. Thanks to our collaborators at , , and others who have made this possible in recent months.

    Poništi
  14. 12. stu 2019.

    Our SVP of Chemistry, Mark Ashwell, and SVP of Biology, Christine Loh, will lead discussions on and quantitative high-throughput screening (qHTS) at tomorrow's Strategy Meeting. Learn more here:

    Poništi
  15. 5. stu 2019.

    Nimbus is looking forward to attending the 34th annual conference this week and participating in ongoing discussions on innovation in . More on the conference here:

    Poništi
  16. 5. stu 2019.

    We're so excited that our stellar EA and long-term member of the Nimbus family, Amy Schnall, is a finalist for the prestigious Colleen Barrett Award for Administrative Excellence at the Boston ! Congrats to Amy and all of the other nominees! 

    Poništi
  17. 31. lis 2019.

    Today we held our annual Halloween celebration at Nimbus. , from our team to yours!

    Poništi
  18. 29. lis 2019.

    ., our VP, head of business development, is joining a panel discussion at 9:45 a.m. this morning at the Drug Development Forum, where he'll discuss innovative deal structures for partnerships. More info here:

    Poništi
  19. 28. lis 2019.

    Nimbus' diverse pipeline includes molecular targets in . We're pleased to join the discussion at the AACR-NCI-EORTC International Conference to help identify novel molecular targets for therapeutics. Learn more:

    Poništi
  20. 21. lis 2019.

    Nimboose is ready for Halloween! Are you? (P.S. Thanks to for the costuming support!)

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·